Erythropoietin (Epo) was once thought to act exclusively in the formation of red blood cells.
As recently reviewed by Smith et al.[Cardiovasc. Res. 59 (2003) 538–548], Epo can also act …

Erythropoietin (EPO), a glycoprotein essential for red blood cell production acts on several
non-erythropoietic tissues. The EPO receptor (EPOR) is expressed in a variety of cell types …

Erythropoietin (Epo) has been thought to act exclusively on erythroid progenitor cells. The
identification of Epo receptor (EpoR) in non-haematopoietic cells and tissues including …

Erythropoietin (EPO) is not solely a hormone charged with regulating the proliferation and
differentiation of erythroid cells. Indeed, EPO is synthesized locally by many cells, especially …

Erythropoietin (EPO) is a hypoxia-induced hormone produced in the kidneys that stimulates
hematopoiesis in the bone marrow. However, recent studies have also shown important …

Erythropoietin (EPO) has been shown to protect neurons from ischemic stroke, but can also
increase thrombotic events and mortality rates in patients with ischemic heart disease. We …

Erythropoietin (EPO) is a hormone known to stimulate hematopoiesis. However, recent
research suggests additional properties of EPO, such as protection against …

Background: Recent studies show that erythropoietin (EPO) plays a protective role in brain
ischemia. In this condition, administration of EPO protects neurons from ischemic damage …

Erythropoietin (EPO) is a therapeutic product of recombinant DNA technology and it has
been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of …

The well-established physiological function of erythropoietin (EPO) is the induction of
erythropoiesis. A growing body of evidence indicates that EPO has tissue-protective effects …